Skip to main content
SpringerLink
Log in

Heterogeneity in endoscopic treatment of Crohn’s disease-associated strictures: An international inflammatory bowel disease specialist survey

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Crohn’s disease (CD) is frequently complicated by intestinal strictures, which are commonly treated by endoscopic balloon dilation (EBD). However, available data on this area of treatment is limited. The aim of this study was to depict the heterogeneity of endoscopic management of CD-associated strictures among international CD specialists to identify common treatment standards.

Methods

IBD experts of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD), the European Crohn’s and Colitis Organization (ECCO), and from the Prospective Value In IBD trials (PROVIT) completed a web-based questionnaire to evaluate their endoscopic experience, practice setting, and number of EBDs performed annually. Additionally, two case scenarios and technical practice parameters were investigated.

Results

A total of 126 subjects from 15 countries completed the survey. The maximal length of dilated stricture was 4.5 ± 1.7 cm. The most commonly used maximal balloon size was graded as 15–18 mm. While 87.2 % of the participants favored EBD for anastomotic strictures, only 58.6 % did so in the case of naïve strictures. Only 35.7 % of physicians dilated actively inflamed strictures. Interventional endoscopists were more likely to dilate only clinically symptomatic strictures (p = 0.046). Surgeons favored surgical treatment of de novo ileocecal strictures compared to gastroenterologists (p = 0.026), reported a shorter stricture length being amendable by EBD (p = 0.045), and more frequently used concomitant therapies (p = 0.001). Operator experience increased the likelihood of EBD use in actively inflamed strictures (p = 0.002), maximum length of stricture, and maximum balloon size (p = 0.001).

Conclusions

EBD is a widely used treatment approach for stricturing CD. Individual approaches differ significantly based on background of the operator, experience level, and practice setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

EBD:

Endoscopic balloon dilatation

SP:

Strictureplasty

TNF-α:

Tumor necrosis factor-alpha

CD:

Crohn’s disease

TTS:

Through-the-scope

psi:

Pounds per square inch

References

  1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–605.

    Article  PubMed  Google Scholar 

  2. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn’s disease: Results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5(12):1430–8.

    Article  PubMed  Google Scholar 

  3. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, et al. Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970–2004). Am J Gastroenterol. 2012;107(11):1693–701.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut. 2005;54(2):237–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bettenworth D, Rieder F. Medical therapy of stricturing Crohn’s disease: What the gut can learn from other organs—a systematic review. Fibrogenesis Tissue Repair. 2014;7(1):5.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: A systematic review and meta-analysis. Dis Colon Rectum. 2007;50(11):1968–86.

    Article  PubMed  Google Scholar 

  7. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25(6):665–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Shivananda S, Hordijk ML, Pena AS, et al. Crohn’s disease: Risk of recurrence and reoperation in a defined population. Gut. 1989;30(7):990–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rieder F, Zimmermann EM, Remzi FH, et al. Crohn’s disease complicated by strictures: A systematic review. Gut. 2013;62(7):1072–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Blomberg B, Rolny P, Jarnerot G. Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy. 1991;23(4):195–8.

    Article  CAS  PubMed  Google Scholar 

  11. Williams AJ, Palmer KR. Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg. 1991;78(4):453–4.

    Article  CAS  PubMed  Google Scholar 

  12. Holtmann M, Wanitschke R, Helisch A, et al. Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn’s disease. Z Gastroenterol. 2003;41(1):11–7. (Anti-TNF-Antikorper zur Therapie von entzundlichen Darmstenosen bei Morbus Crohn).

  13. Hassan C, Zullo A, De Francesco V, et al. Systematic review: Endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther. 2007;26(11–12):1457–64.

    Article  CAS  PubMed  Google Scholar 

  14. Saunders BP, Brown GJ, Lemann M, et al. Balloon dilation of ileocolonic strictures in Crohn’s disease. Endoscopy. 2004;36(11):1001–7.

    Article  CAS  PubMed  Google Scholar 

  15. Felley C, Vader JP, Juillerat P, et al. Appropriate therapy for fistulizing and fibrostenotic Crohn’s disease: Results of a multidisciplinary expert panel—EPACT II. J Crohns Colitis. 2009;3(4):250–6.

    Article  PubMed  Google Scholar 

  16. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.

    Article  PubMed  Google Scholar 

  17. East JE, Brooker JC, Rutter MD, et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol. 2007;5(9):1065–9.

    Article  PubMed  Google Scholar 

  18. Thomas-Gibson S, Brooker JC, Hayward CM, et al. Colonoscopic balloon dilation of Crohn’s strictures: A review of long-term outcomes. Eur J Gastroenterol Hepatol. 2003;15(5):485–8.

    PubMed  Google Scholar 

  19. Chen M, Shen B. Endoscopic therapy in Crohn’s disease: Principle, preparation, and technique. Inflamm Bowel Dis. 2015;21(9):2222–40.

    Article  PubMed  Google Scholar 

  20. Bettenworth D, Lopez R, Gustavsson A, et al. Efficacy, safety and long term outcome of endoscopic dilation therapy for stricturing Crohn’s disease—a combined analysis of 3252 endoscopic balloon dilations procedures. Gastroenterology. 2015;147(5):S239–S240. DDW abstract #2152144.

  21. Atreja A, Aggarwal A, Dwivedi S, et al. Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures. J Crohns Colitis. 2014;8(5):392–400.

    Article  PubMed  Google Scholar 

  22. Thienpont C, D’Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut. 2010;59(3):320–4.

    Article  CAS  PubMed  Google Scholar 

  23. Paine E, Shen B. Endoscopic therapy in inflammatory bowel diseases (with videos). Gastrointest Endosc. 2013;78(6):819–35.

    Article  PubMed  Google Scholar 

  24. Thienpont C, Van Assche G. Endoscopic and medical management of fibrostenotic Crohn’s disease. Dig Dis. 2014;32(Suppl 1):35–8.

    Article  PubMed  Google Scholar 

  25. Krauss E, Agaimy A, Gottfried A, et al. Long term follow up of through-the-scope balloon dilation as compared to strictureplasty and bowel resection of intestinal strictures in crohn’s disease. Int J Clin Exp Pathol. 2014;7(11):7419–31.

    PubMed  PubMed Central  Google Scholar 

  26. Bharadwaj S, Fleshner P, Shen B. Therapeutic armamentarium for stricturing Crohn’s disease: Medical versus endoscopic versus surgical approaches. Inflamm Bowel Dis. 2015;21(9):2194–213.

    Article  PubMed  Google Scholar 

  27. Wibmer AG, Kroesen AJ, Grone J, et al. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease–review of the literature. Int J Colorectal Dis. 2010;25(10):1149–57.

    Article  PubMed  Google Scholar 

  28. de’Angelis N, Carra MC, Borrelli O, et al. Short- and long-term efficacy of endoscopic balloon dilation in Crohn’s disease strictures. World J Gastroenterol. 2013;19(17):2660–7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gustavsson A, Magnuson A, Blomberg B, et al. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn’s disease. Aliment Pharmacol Ther. 2012;36(2):151–8.

    Article  CAS  PubMed  Google Scholar 

  30. Endo K, Takahashi S, Shiga H, et al. Short and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease strictures. World J Gastroenterol. 2013;19(1):86–91.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Couckuyt H, Gevers AM, Coremans G, et al. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: A prospective long-term analysis. Gut. 1995;36(4):577–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Nomura E, Takagi S, Kikuchi T, et al. Efficacy and safety of endoscopic balloon dilation for Crohn’s strictures. Dis Colon Rectum. 2006;49(10 Suppl):S59–67.

    Article  PubMed  Google Scholar 

  33. Chatu S, Subramanian V, Saxena S, et al. The role of thiopurines in reducing the need for surgical resection in Crohn’s disease: A systematic review and meta-analysis. Am J Gastroenterol. 2014;109(1):23–34 quiz 5.

    Article  CAS  PubMed  Google Scholar 

  34. Loras C, Perez-Roldan F, Gornals JB, et al. Endoscopic treatment with self-expanding metal stents for Crohn’s disease strictures. Aliment Pharmacol Ther. 2012;36(9):833–9.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a research fellowship from the Faculty of Medicine, Westfälische Wilhelms-Universität Münster, awarded to D.B. This work was supported by grants from the National Institutes of Health (1T32DK083251) and the European Crohn’s and Colitis Foundation, awarded to F.R.

Author information

Author notes

    Authors and Affiliations

    1. Department of Medicine B, University Hospital of Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany

      Dominik Bettenworth

    2. Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

      Rocio Lopez

    3. Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium

      Pieter Hindryckx

    4. Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA

      Barrett G. Levesque

    5. Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

      Florian Rieder

    6. Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

      Florian Rieder

    Authors
    1. Dominik Bettenworth
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Rocio Lopez
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Pieter Hindryckx
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Barrett G. Levesque
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Florian Rieder
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Dominik Bettenworth.

    Ethics declarations

    Conflict of interest

    The authors declare that they have no conflict of interest.

    Additional information

    D. Bettenworth and F. Rieder both contributed equally to this manuscript.

    Electronic supplementary material

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Bettenworth, D., Lopez, R., Hindryckx, P. et al. Heterogeneity in endoscopic treatment of Crohn’s disease-associated strictures: An international inflammatory bowel disease specialist survey. J Gastroenterol 51, 939–948 (2016). https://doi.org/10.1007/s00535-016-1172-6

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00535-016-1172-6

    Keywords

    Search

    Navigation